Tagged: #satyashreenivas

The growth of transcatheter aortic valve replacements (TAVRs) and MitraClips has been “revolutionary,” says Satya Shreenivas, MD, assistant professor and director of the structural heart disease program at the University of Cincinnati Heart, Lung and Vascular Institute. The Institute’s focus is implanting heart valves nonsurgically by transcatheter aortic valve replacement as well as nonsurgical repair

Learn More →

Interview with: Imran Arif, MD Professor of Clinical Medicine Division of Cardiovascular Health and Disease University of Cincinnati Satya S. Shreenivas, MD Assistant Professor of Clinical Medicine Division of Cardiovascular Health and Disease University of CIncinnati

Learn More →

An unusually large patient cohort and state-of-the-art medical facilities have expedited rapid growth of the Transcatheter Aortic Valve Replacement (TAVR) Program at the University of Cincinnati Medical Center. As with many other cardiac diseases, such as coronary blockages and arrhythmias, valvular heart disease is now increasingly being treated in a minimally-invasive manner. This is especially important

Learn More →